CCK-8 assays showed significantly reduced cell proliferation 24 hours post-treatment (Figure 7E), while colony formation assays (Figure 7F) confirmed abemaciclib’s ability to markedly decrease colony numbers, indicating effective inhibition of tumor cell proliferation through HOXC6 targeting. The gene discussed is HOXC6; the disease is neoplasm.